Vanda Pharmaceuticals (VNDA) Enterprise Value Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Vanda Pharmaceuticals | 379.35 Mn | 177.04 Mn | 48.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.76% |
| Dec 31, 2025 | 6.42% |
| Sep 30, 2025 | 3.36% |
| Jun 30, 2025 | 0.86% |
| Mar 31, 2025 | -1.77% |
| Dec 31, 2024 | -3.72% |
| Sep 30, 2024 | -9.61% |
| Jun 30, 2024 | -6.71% |
| Mar 31, 2024 | -8.03% |
| Dec 31, 2023 | -8.57% |
| Sep 30, 2023 | -15.28% |
| Jun 30, 2023 | -16.18% |
| Mar 31, 2023 | -15.05% |
| Dec 31, 2022 | -26.62% |
| Sep 30, 2022 | -26.59% |
| Jun 30, 2022 | -26.31% |
| Mar 31, 2022 | -25.87% |
| Dec 31, 2021 | -16.48% |
| Sep 30, 2021 | -23.28% |
| Jun 30, 2021 | -23.86% |
| Mar 31, 2021 | -22.28% |
| Dec 31, 2020 | -20.76% |
| Sep 30, 2020 | -19.29% |
| Jun 30, 2020 | -18.31% |
| Mar 31, 2020 | -18.38% |
| Dec 31, 2019 | -19.18% |
| Sep 30, 2019 | -33.49% |
| Jun 30, 2019 | -34.53% |
| Mar 31, 2019 | -21.68% |
| Dec 31, 2018 | -14.57% |
| Sep 30, 2018 | -11.09% |
| Jun 30, 2018 | -17.41% |
| Mar 31, 2018 | -17.54% |
| Dec 31, 2017 | -3.56% |
| Sep 30, 2017 | -0.80% |
| Jun 30, 2017 | 1.07% |
| Mar 31, 2017 | 2.61% |
| Dec 31, 2016 | -6.27% |
| Sep 30, 2016 | 2.46% |
| Jun 30, 2016 | 6.31% |
| Mar 31, 2016 | -21.37% |
| Dec 31, 2015 | 6.28% |
| Sep 30, 2015 | -7.09% |
| Jun 30, 2015 | -0.14% |
| Dec 31, 2014 | 8.76% |